← Back to homepage
Neutral
New UK antibiotics alert as 'defect' notice issued
Sources
1
Coverage
Limited spectrum
Sentiment
0.00
◀ Left 100%Centre 0%Right 0% ▶
How we rate bias →auto_awesome
NEWSDECK ANALYSIS
The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for ensuring the safety and efficacy of medicines in the UK, and a Class 4 Medicines Defect Notification is a type of alert issued when a defect is found in a medicinal product that is not likely to cause significant harm to patients. The MHRA's notification process is in place to quickly inform healthcare professionals and patients of potential issues with medicines, allowing for prompt action to be taken. This type of notification is typically issued for defects that may affect the quality or performance of a medicine, but are unlikely to have serious consequences for patients.
This story is currently only covered by one source from a single part of the political spectrum. NewsDeck will update this page automatically if other outlets pick up the story.
NewsDeck Poll
Do you think this story is being covered fairly across the political spectrum?
Loading…
Left
(1)
Mirror News
New UK antibiotics alert as 'defect' notice issued
The MHRA has issued a Class 4 Medicines Defect Notification for certain batches
30 Jun, 08:40
Centre
(0)
No coverage from this perspective yet
Right
(0)
No coverage from this perspective yet